Ablative therapy for movement disorders: Complications in the treatment of movement disorders

D. F. Louw, Kim Burchiel

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Presently, there is a renaissance in the surgical treatment of movement disorders. Prompted by the growing recognition of the limitations of drug therapy, this resurgence has been further promoted by progress in neuronal transplantation, advances in neuroimaging and stereotactic surgical techniques, and innovative therapies, such as deep brain stimulation for abnormal movements. Mortality associated with thalamotomy and pallidotomy is rare, but morbidity is not inconsiderable, particularly in the elderly and those with preexisting brain damage. Judicious patient selection and physiologic confirmation of stereotactic targets are cornerstones to complication avoidance.

Original languageEnglish (US)
Pages (from-to)367-373
Number of pages7
JournalNeurosurgery Clinics of North America
Volume9
Issue number2
StatePublished - 1998

Fingerprint

Pallidotomy
Stereotaxic Techniques
Investigational Therapies
Deep Brain Stimulation
Dyskinesias
Movement Disorders
Neuroimaging
Patient Selection
Transplantation
Morbidity
Drug Therapy
Mortality
Brain
Therapeutics
Renaissance

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Ablative therapy for movement disorders : Complications in the treatment of movement disorders. / Louw, D. F.; Burchiel, Kim.

In: Neurosurgery Clinics of North America, Vol. 9, No. 2, 1998, p. 367-373.

Research output: Contribution to journalArticle

@article{11f2fe271b544f1f9276af425af0584a,
title = "Ablative therapy for movement disorders: Complications in the treatment of movement disorders",
abstract = "Presently, there is a renaissance in the surgical treatment of movement disorders. Prompted by the growing recognition of the limitations of drug therapy, this resurgence has been further promoted by progress in neuronal transplantation, advances in neuroimaging and stereotactic surgical techniques, and innovative therapies, such as deep brain stimulation for abnormal movements. Mortality associated with thalamotomy and pallidotomy is rare, but morbidity is not inconsiderable, particularly in the elderly and those with preexisting brain damage. Judicious patient selection and physiologic confirmation of stereotactic targets are cornerstones to complication avoidance.",
author = "Louw, {D. F.} and Kim Burchiel",
year = "1998",
language = "English (US)",
volume = "9",
pages = "367--373",
journal = "Neurosurgery Clinics of North America",
issn = "1042-3680",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Ablative therapy for movement disorders

T2 - Complications in the treatment of movement disorders

AU - Louw, D. F.

AU - Burchiel, Kim

PY - 1998

Y1 - 1998

N2 - Presently, there is a renaissance in the surgical treatment of movement disorders. Prompted by the growing recognition of the limitations of drug therapy, this resurgence has been further promoted by progress in neuronal transplantation, advances in neuroimaging and stereotactic surgical techniques, and innovative therapies, such as deep brain stimulation for abnormal movements. Mortality associated with thalamotomy and pallidotomy is rare, but morbidity is not inconsiderable, particularly in the elderly and those with preexisting brain damage. Judicious patient selection and physiologic confirmation of stereotactic targets are cornerstones to complication avoidance.

AB - Presently, there is a renaissance in the surgical treatment of movement disorders. Prompted by the growing recognition of the limitations of drug therapy, this resurgence has been further promoted by progress in neuronal transplantation, advances in neuroimaging and stereotactic surgical techniques, and innovative therapies, such as deep brain stimulation for abnormal movements. Mortality associated with thalamotomy and pallidotomy is rare, but morbidity is not inconsiderable, particularly in the elderly and those with preexisting brain damage. Judicious patient selection and physiologic confirmation of stereotactic targets are cornerstones to complication avoidance.

UR - http://www.scopus.com/inward/record.url?scp=0031940256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031940256&partnerID=8YFLogxK

M3 - Article

C2 - 9495898

AN - SCOPUS:0031940256

VL - 9

SP - 367

EP - 373

JO - Neurosurgery Clinics of North America

JF - Neurosurgery Clinics of North America

SN - 1042-3680

IS - 2

ER -